The Asia Pacific Vacuum Blood Collection Tube Market would witness market growth of 2.4% CAGR during the forecast period (2022-2028).
The growing prevalence of cancer has raised the necessity for early diagnostic tests. Patients are selecting non-invasive diagnostic tools because more people are becoming aware of their benefits. A promising and flexible non-invasive cancer diagnostic technique, among them, is a liquid biopsy. Circulating tumor cells, tumor-free nucleic acids, or cells originating from other diseased organs are used in liquid biopsy analysis.
Particularly among the senior population, this technique is growing in popularity. Blood transfusions are becoming more common in surgical operations and accident instances, which is propelling the market toward development and expansion. The rising accessibility of diagnostic tests and their use in different hospitals are other factors driving the vacuum blood collection tube market.
China has one of the oldest populations in the world. By 2040, 28% of China's population is anticipated to be older than 60 due to increased life expectancy and declining birth rates. This significant population change brings both new possibilities and challenges to public health and socioeconomic growth. Of particular importance is the creation of an integrated system that meets the social and health needs of older people while ensuring that everyone has access to healthcare, regardless of location. China has been investigating cutting-edge methods for enhancing access to integrated care. The demand for cutting-edge healthcare facilities will increase as the number of elderly grows. All of these factors are anticipated to boost market expansion in the APAC region.
The China market dominated the Asia Pacific Vacuum Blood Collection Tube Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $286 million by 2028.The Japan market is estimated to grow a CAGR of 1.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 3% during (2022 - 2028).
Based on Material, the market is segmented into PET/Plastic and Glass. Based on Application, the market is segmented into Blood Routine Examination, Serology & Immunology, Blood Sugar Assay, Coagulation Tests & Genetic Studies and Others. Based on End-use, the market is segmented into Pathology Laboratories, Hospitals & Clinics and Blood Banks. Based on Type, the market is segmented into Serum Separating Tubes, Plasma Separation Tubes, EDTA Tubes, Rapid Serum Tubes, Coagulation Tubes and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Vacuum Blood Collection Tube Market is Projected to reach USD 3.2 Billion by 2028, at a CAGR of 1.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Cardinal Health, Inc., Sekisui Chemical Co., Ltd., Greiner AG, Hindustan Syringes & Medical Devices Ltd., OÜ InterVacTechnology, Advin Health Care, AdvaCare Pharma, MB Plastic Industries, and CML Biotech (P) Ltd.
By Material
By Application
By End-use
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
